Get the Stockscreener App
2.405
2.63%
-0.065
Heron Therapeutics Inc Stock (HRTX) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
1.28%
34.67
|
34.23 | 31.43 | 31.76 | 29.61 |
| Cost Of Revenue |
14.58%
8.444
|
9.885 | 18.21 | 20.16 | 16.85 |
| Gross Profit |
7.71%
26.23
|
24.35 | 13.23 | 11.60 | 12.76 |
Operating Expenses
|
10.25%
31.02
|
34.57 | 38.16 | 54.01 | 45.82 |
| Benefits Costs and Expenses |
10.25%
31.02
|
34.57 | 38.16 | 74.17 | 62.68 |
| Costs And Expenses |
10.25%
31.02
|
34.57 | 38.16 | 74.17 | 62.68 |
| Operating Income/Loss |
53.05%
-4.798
|
-10.22 | -24.93 | -42.40 | -33.06 |
| Income/Loss From Continuing Operations Before Tax |
1,188%
3.646
|
-0.335 | -6.721 | -42.06 | -32.77 |
| Income/Loss From Continuing Operations After Tax |
70.53%
-3.16
|
-10.72 | -25.01 | -42.06 | -32.77 |
|
Net Income/Loss
|
70.53%
-3.16
|
-10.72 | -25.01 | -42.06 | -32.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,346%
151.20
|
4.388 | 144.99 | 119.72 | 119.25 |
| Diluted Average Shares |
3,346%
151.20
|
4.388 | 144.99 | 119.72 | 119.25 |
| Basic Earnings Per Share |
60.00%
-0.02
|
-0.05 | -0.17 | -0.35 | -0.27 |
| Diluted Earnings Per Share |
60.00%
-0.02
|
-0.05 | -0.17 | -0.35 | -0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):